Insulin-like growth factor-I augments erythropoietin-induced proliferation through enhanced tyrosine phosphorylation of STAT5

Yu Okajima, Itaru Matsumura, Tetsuo Nishiura, Koji Hashimoto, Hitoshi Yoshida, Jun Ishikawa, Hiroshi Wakao, Akihiko Yoshimura, Yuzuru Kanakura, Yoshiaki Tomiyama, Yuji Matsuzawa

Research output: Contribution to journalArticle

30 Citations (Scopus)

Abstract

Insulin-like growth factor (IGF-I) is known to synergistically stimulate the proliferation of hematopoietic cells in combination with other hematopoietic growth factors. However, the precise mechanism underlying the cooperative effects of IGF-I is unknown. In a human interleukin-3 or erythropoietin (EPO)-dependent cell line, F-36P, IGF-I alone failed to stimulate DNA synthesis but did augment the EPO-dependent DNA synthesis of F- 36P cells. The treatment of F-36P cells with a combination of EPO and IGF-I (EPO/IGF-I) was found to enhance EPO-induced tyrosine phosphorylation of STAT5, whereas IGF-I alone did not. Furthermore, c-CIS mRNA expression, one of the target molecules of STAT5, was more effectively induced by EPO/IGF-I than by EPO alone. To examine the mechanisms of the EPO- and EPO/IGF-I- induced proliferation of F-36P cells, we expressed dominant negative (dn) mutants of STAT5 and Ras in an inducible system. The EPO-induced DNA synthesis and the cooperative effect of EPO/IGF-I were significantly inhibited by the inducible expression of dn-STAT5 or dn-Ras. In addition, the inducible expression of dn-Ras abolished the IGF-I-enhanced tyrosine phosphorylation of STAT5. These results suggest that IGF-I may augment EPO- induced proliferation by enhancing tyrosine phosphorylation of STAT5 and raise the possibility that Ras may be involved in the augmentation of STAT5 tyrosyl phosphorylation.

Original languageEnglish
Pages (from-to)22877-22883
Number of pages7
JournalJournal of Biological Chemistry
Volume273
Issue number36
DOIs
Publication statusPublished - 1998 Sep 4
Externally publishedYes

Fingerprint

Phosphorylation
Erythropoietin
Insulin-Like Growth Factor I
Tyrosine
DNA
Interleukin-3
Somatomedins
Intercellular Signaling Peptides and Proteins
Cells
Cell Proliferation

ASJC Scopus subject areas

  • Biochemistry

Cite this

Okajima, Y., Matsumura, I., Nishiura, T., Hashimoto, K., Yoshida, H., Ishikawa, J., ... Matsuzawa, Y. (1998). Insulin-like growth factor-I augments erythropoietin-induced proliferation through enhanced tyrosine phosphorylation of STAT5. Journal of Biological Chemistry, 273(36), 22877-22883. https://doi.org/10.1074/jbc.273.36.22877

Insulin-like growth factor-I augments erythropoietin-induced proliferation through enhanced tyrosine phosphorylation of STAT5. / Okajima, Yu; Matsumura, Itaru; Nishiura, Tetsuo; Hashimoto, Koji; Yoshida, Hitoshi; Ishikawa, Jun; Wakao, Hiroshi; Yoshimura, Akihiko; Kanakura, Yuzuru; Tomiyama, Yoshiaki; Matsuzawa, Yuji.

In: Journal of Biological Chemistry, Vol. 273, No. 36, 04.09.1998, p. 22877-22883.

Research output: Contribution to journalArticle

Okajima, Y, Matsumura, I, Nishiura, T, Hashimoto, K, Yoshida, H, Ishikawa, J, Wakao, H, Yoshimura, A, Kanakura, Y, Tomiyama, Y & Matsuzawa, Y 1998, 'Insulin-like growth factor-I augments erythropoietin-induced proliferation through enhanced tyrosine phosphorylation of STAT5', Journal of Biological Chemistry, vol. 273, no. 36, pp. 22877-22883. https://doi.org/10.1074/jbc.273.36.22877
Okajima, Yu ; Matsumura, Itaru ; Nishiura, Tetsuo ; Hashimoto, Koji ; Yoshida, Hitoshi ; Ishikawa, Jun ; Wakao, Hiroshi ; Yoshimura, Akihiko ; Kanakura, Yuzuru ; Tomiyama, Yoshiaki ; Matsuzawa, Yuji. / Insulin-like growth factor-I augments erythropoietin-induced proliferation through enhanced tyrosine phosphorylation of STAT5. In: Journal of Biological Chemistry. 1998 ; Vol. 273, No. 36. pp. 22877-22883.
@article{814defe09280402bb834bee5aa4c2593,
title = "Insulin-like growth factor-I augments erythropoietin-induced proliferation through enhanced tyrosine phosphorylation of STAT5",
abstract = "Insulin-like growth factor (IGF-I) is known to synergistically stimulate the proliferation of hematopoietic cells in combination with other hematopoietic growth factors. However, the precise mechanism underlying the cooperative effects of IGF-I is unknown. In a human interleukin-3 or erythropoietin (EPO)-dependent cell line, F-36P, IGF-I alone failed to stimulate DNA synthesis but did augment the EPO-dependent DNA synthesis of F- 36P cells. The treatment of F-36P cells with a combination of EPO and IGF-I (EPO/IGF-I) was found to enhance EPO-induced tyrosine phosphorylation of STAT5, whereas IGF-I alone did not. Furthermore, c-CIS mRNA expression, one of the target molecules of STAT5, was more effectively induced by EPO/IGF-I than by EPO alone. To examine the mechanisms of the EPO- and EPO/IGF-I- induced proliferation of F-36P cells, we expressed dominant negative (dn) mutants of STAT5 and Ras in an inducible system. The EPO-induced DNA synthesis and the cooperative effect of EPO/IGF-I were significantly inhibited by the inducible expression of dn-STAT5 or dn-Ras. In addition, the inducible expression of dn-Ras abolished the IGF-I-enhanced tyrosine phosphorylation of STAT5. These results suggest that IGF-I may augment EPO- induced proliferation by enhancing tyrosine phosphorylation of STAT5 and raise the possibility that Ras may be involved in the augmentation of STAT5 tyrosyl phosphorylation.",
author = "Yu Okajima and Itaru Matsumura and Tetsuo Nishiura and Koji Hashimoto and Hitoshi Yoshida and Jun Ishikawa and Hiroshi Wakao and Akihiko Yoshimura and Yuzuru Kanakura and Yoshiaki Tomiyama and Yuji Matsuzawa",
year = "1998",
month = "9",
day = "4",
doi = "10.1074/jbc.273.36.22877",
language = "English",
volume = "273",
pages = "22877--22883",
journal = "Journal of Biological Chemistry",
issn = "0021-9258",
publisher = "American Society for Biochemistry and Molecular Biology Inc.",
number = "36",

}

TY - JOUR

T1 - Insulin-like growth factor-I augments erythropoietin-induced proliferation through enhanced tyrosine phosphorylation of STAT5

AU - Okajima, Yu

AU - Matsumura, Itaru

AU - Nishiura, Tetsuo

AU - Hashimoto, Koji

AU - Yoshida, Hitoshi

AU - Ishikawa, Jun

AU - Wakao, Hiroshi

AU - Yoshimura, Akihiko

AU - Kanakura, Yuzuru

AU - Tomiyama, Yoshiaki

AU - Matsuzawa, Yuji

PY - 1998/9/4

Y1 - 1998/9/4

N2 - Insulin-like growth factor (IGF-I) is known to synergistically stimulate the proliferation of hematopoietic cells in combination with other hematopoietic growth factors. However, the precise mechanism underlying the cooperative effects of IGF-I is unknown. In a human interleukin-3 or erythropoietin (EPO)-dependent cell line, F-36P, IGF-I alone failed to stimulate DNA synthesis but did augment the EPO-dependent DNA synthesis of F- 36P cells. The treatment of F-36P cells with a combination of EPO and IGF-I (EPO/IGF-I) was found to enhance EPO-induced tyrosine phosphorylation of STAT5, whereas IGF-I alone did not. Furthermore, c-CIS mRNA expression, one of the target molecules of STAT5, was more effectively induced by EPO/IGF-I than by EPO alone. To examine the mechanisms of the EPO- and EPO/IGF-I- induced proliferation of F-36P cells, we expressed dominant negative (dn) mutants of STAT5 and Ras in an inducible system. The EPO-induced DNA synthesis and the cooperative effect of EPO/IGF-I were significantly inhibited by the inducible expression of dn-STAT5 or dn-Ras. In addition, the inducible expression of dn-Ras abolished the IGF-I-enhanced tyrosine phosphorylation of STAT5. These results suggest that IGF-I may augment EPO- induced proliferation by enhancing tyrosine phosphorylation of STAT5 and raise the possibility that Ras may be involved in the augmentation of STAT5 tyrosyl phosphorylation.

AB - Insulin-like growth factor (IGF-I) is known to synergistically stimulate the proliferation of hematopoietic cells in combination with other hematopoietic growth factors. However, the precise mechanism underlying the cooperative effects of IGF-I is unknown. In a human interleukin-3 or erythropoietin (EPO)-dependent cell line, F-36P, IGF-I alone failed to stimulate DNA synthesis but did augment the EPO-dependent DNA synthesis of F- 36P cells. The treatment of F-36P cells with a combination of EPO and IGF-I (EPO/IGF-I) was found to enhance EPO-induced tyrosine phosphorylation of STAT5, whereas IGF-I alone did not. Furthermore, c-CIS mRNA expression, one of the target molecules of STAT5, was more effectively induced by EPO/IGF-I than by EPO alone. To examine the mechanisms of the EPO- and EPO/IGF-I- induced proliferation of F-36P cells, we expressed dominant negative (dn) mutants of STAT5 and Ras in an inducible system. The EPO-induced DNA synthesis and the cooperative effect of EPO/IGF-I were significantly inhibited by the inducible expression of dn-STAT5 or dn-Ras. In addition, the inducible expression of dn-Ras abolished the IGF-I-enhanced tyrosine phosphorylation of STAT5. These results suggest that IGF-I may augment EPO- induced proliferation by enhancing tyrosine phosphorylation of STAT5 and raise the possibility that Ras may be involved in the augmentation of STAT5 tyrosyl phosphorylation.

UR - http://www.scopus.com/inward/record.url?scp=14444275276&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=14444275276&partnerID=8YFLogxK

U2 - 10.1074/jbc.273.36.22877

DO - 10.1074/jbc.273.36.22877

M3 - Article

VL - 273

SP - 22877

EP - 22883

JO - Journal of Biological Chemistry

JF - Journal of Biological Chemistry

SN - 0021-9258

IS - 36

ER -